HealthInvest Partners AB as of Dec. 31, 2017
Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 16 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anika Therapeutics (ANIK) | 13.0 | $6.2M | 115k | 53.91 | |
| Charles River Laboratories (CRL) | 6.2 | $2.9M | 27k | 109.46 | |
| Laboratory Corp. of America Holdings (LH) | 6.0 | $2.8M | 18k | 159.49 | |
| Quest Diagnostics Incorporated (DGX) | 5.9 | $2.8M | 29k | 98.49 | |
| Cardinal Health (CAH) | 5.9 | $2.8M | 46k | 61.27 | |
| McKesson Corporation (MCK) | 5.9 | $2.8M | 18k | 155.96 | |
| Ligand Pharmaceuticals In (LGND) | 5.8 | $2.8M | 20k | 136.93 | |
| Anthem (ELV) | 5.8 | $2.8M | 12k | 225.04 | |
| Medtronic (MDT) | 5.8 | $2.8M | 34k | 80.76 | |
| Pfizer (PFE) | 5.7 | $2.7M | 75k | 36.22 | |
| CIGNA Corporation | 5.7 | $2.7M | 13k | 203.06 | |
| Waters Corporation (WAT) | 5.7 | $2.7M | 14k | 193.21 | |
| Eli Lilly & Co. (LLY) | 5.7 | $2.7M | 32k | 84.47 | |
| Biogen Idec (BIIB) | 5.7 | $2.7M | 8.4k | 318.57 | |
| Bristol Myers Squibb (BMY) | 5.6 | $2.7M | 43k | 61.29 | |
| Gilead Sciences (GILD) | 5.5 | $2.6M | 36k | 71.63 |
